255Ac-OncoACP3
N/A
Report date: 2025/11/24 17:31:45
NME
Base Information
Drug Name255Ac-OncoACP3
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhilochem AG
China Registration ClassN/A
Develop Information
Active CompaniesPhilochem AGRayzeBio IncBristol-Myers Squibb Company
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A